People are being urged to take part in a new consultation this week focused on ‘low priority’ prescribing.
NHS England is asking for views nationally on a number of products that are deems to be items of relatively low clinical effectiveness, items which are clinically effective but where more cost effective items are available, or items which are clinically effective but, due to the nature of the item, are deemed a low priority for NHS funding.
The items that the NHS wants to hear views on are:
- Silk garments
- Aliskiren – used to treat blood pressure
- Amiodarone – used to treat abnormal heart rhythms
- Bath and shower emollient preparations
- Dronedarone – used to treat atrial fibrillation
- Minocycline – used to treat acne
- Blood glucose testing strips
Needles for pre-filled and reusable insulin pens – proposed recommendations are focused on substitution for more cost-effective products rather than a reduction in prescribing of these items.
The national consultation is open for three months until 28 February 2019.
After this date, feedback will be collated and will help to inform guidance that will be issued to CCGs across the country.
It comes after NHS England agreed the end to the routine prescribing of 18 low value items for 35 minor conditions where products are available over the counter, often at lower cost, such as paracetamol and cough mixture.
The initiatives could free up more than £200 million a year for reinvestment in frontline care.
Together the new items being consulted on cost the NHS more than £68 million a year.
As the NHS draws up its long term plan, the use of medicines and what is available on prescription will be a key element.
Please have your say and complete the prescriptions consultation.